Latest news
Loading news…
DISCO Pharmaceuticals
ActiveOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 LowHeat score — how much recent activity & attention the company has (web traffic, news, hiring).📈 Low growthGrowth score — momentum trend across web traffic, headcount and other growth signals. Cologne, Nordrhein-Westfalen, Germany Founded 2022 11-50 employees For Profit
DISCO Pharmaceuticals is a firm that specializes in large-scale surfaceome unlocking of cancer cells.
Total Funding
Available in Pro Last Funding
Available in Pro Acquisitions
0
Monthly Visits
Available in Pro Contacts
4
Patents
0
4 trademarks
Company Details
Funding & Financials
Pro- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
IPO & Stock
- IPO status
- Private
Web Traffic
Pro- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Technology & IP
- Active technologies
- 3
- Patents granted
- 0
- Trademarks
- 4
- IT spend
- $382K
Company Info
- Founded
- 2022
- Employees
- 11-50
- Operating status
- Active
- Company type
- For Profit
- Org types
- company
- News articles
- 26
- HQ
- Cologne, Nordrhein-Westfalen, Germany
- Region
- European Union (EU), Europe, Middle East, and Africa (EMEA)
Signals & Scores
- Heat score
- Low
- Growth score
- Low
- Trend (7d)
- -0.3
- Trend (30d)
- 2
- Trend (90d)
- -1.4
- Last leadership hire
- Dec 11, 2025
Key People at DISCO Pharmaceuticals
Chief Executive Officer
Strategic Advisor
4
professional contacts at DISCO Pharmaceuticals
Contact execs at DISCO Pharmaceuticals →Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Recent News related to DISCO Pharmaceuticals
Loading news…
FAQs about DISCO Pharmaceuticals
People who checked this page also checked these
Browse the full Acquirezy directory.